NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/30/2025
Back to search
Official data from USPTO
PIVEZLA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
05/31/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
11/18/2020
Registration date
08/24/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/24/2021
Last transaction
05/31/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
JACKSON, WILLIAM
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Glaxo Group Limited
Representatives
Legal Brand Protection, GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
Publications
History of USPTO decisions and trademark events.
15 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
11/08/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/20/2021
FIMP
FINAL DISPOSITION PROCESSED
10/15/2021
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
09/23/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/24/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NPUB
NOTICE OF PUBLICATION
05/19/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2021
DOCK
ASSIGNED TO EXAMINER
04/30/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/15/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/14/2021
Continuous trademark protection
Get notified about every new filing that threatens PIVEZLA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.